Cargando…

IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment

BACKGROUND: Interleukin-33 is a cytokine endowed with pro- and anti-inflammatory properties that plays a still poorly defined role in the pathogenesis of a number of central nervous system (CNS) conditions including Alzheimer’s disease (AD). We analyzed this cytokine and its decoy receptor sST2 in A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saresella, Marina, Marventano, Ivana, Piancone, Federica, La Rosa, Francesca, Galimberti, Daniela, Fenoglio, Chiara, Scarpini, Elio, Clerici, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276088/ https://www.ncbi.nlm.nih.gov/pubmed/32505187 http://dx.doi.org/10.1186/s12974-020-01806-4

Ejemplares similares

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2023)

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2021)

Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients
por: La Rosa, Francesca, et al.
Publicado: (2022)

Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2017)

The Role of the Inflammasome in Neurodegenerative Diseases
por: Piancone, Federica, et al.
Publicado: (2021)

Neuroinflammation and Brain Functional Disconnection in Alzheimer’s Disease
por: Baglio, Francesca, et al.
Publicado: (2013)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Inflammatory Responses to Monomeric and Aggregated α-Synuclein in Peripheral Blood of Parkinson Disease Patients
por: Piancone, Federica, et al.
Publicado: (2021)

Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia(1)
por: Fenoglio, Chiara, et al.
Publicado: (2018)

The Association of Serum IL-33 and sST2 with Breast Cancer
por: Yang, Zhi-Ping, et al.
Publicado: (2015)

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011)

Modulation of Neuroendocrine and Immunological Biomarkers Following Rehabilitation in Sarcopenic Patients
por: Piancone, Federica, et al.
Publicado: (2022)

Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
por: Saresella, Marina, et al.
Publicado: (2022)

Increased Levels of Beta-Endorphin and Noradrenaline after a Brief High-Impact Multidimensional Rehabilitation Program in Multiple Sclerosis
por: d’Arma, Alessia, et al.
Publicado: (2022)

Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients
por: La Rosa, Francesca, et al.
Publicado: (2019)

Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis
por: Piancone, Federica, et al.
Publicado: (2018)

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
por: Buccellato, Francesca Romana, et al.
Publicado: (2021)

Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure
por: Firouzabadi, Negar, et al.
Publicado: (2020)

Alteration of the IL-33-sST2 pathway in hypertensive patients and a mouse model
por: Yin, Xiaoyun, et al.
Publicado: (2019)

The Clinical Significance of Serum IL-33 and sST2 Alterations in the Post-Stroke Depression
por: Xu, Meirong, et al.
Publicado: (2021)

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
por: Saresella, Marina, et al.
Publicado: (2017)

Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model
por: Takenaga, Keizo, et al.
Publicado: (2020)

An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders
por: Fenoglio, Chiara, et al.
Publicado: (2013)

MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis
por: Fenoglio, Chiara, et al.
Publicado: (2012)

B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity
por: Piancone, Federica, et al.
Publicado: (2016)

Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer’s Disease
por: Cova, Ilaria, et al.
Publicado: (2016)

Alterations of natural killer cells activatory molecules phenotype and function in mothers of ASD children: a pilot study
por: Saresella, Marina, et al.
Publicado: (2023)

Deregulation of IL-37 and its miRNAs modulators in sarcopenic patients after rehabilitation
por: La Rosa, Francesca, et al.
Publicado: (2021)

Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
por: Akimoto, Miho, et al.
Publicado: (2016)

Increased Expression of sST2 in Early HIV Infected Patients Attenuated the IL-33 Induced T Cell Responses
por: Wu, Xian, et al.
Publicado: (2018)

Predictive Values of Serum IL-33 and sST2 in Endotypes and Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps
por: Zhang, Yanni, et al.
Publicado: (2022)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

Corrigendum: Increased Expression of sST2 in Early HIV Infected Patients Attenuated the IL-33 Induced T Cell Responses
por: Wu, Xian, et al.
Publicado: (2020)

CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia
por: Heywood, Wendy E., et al.
Publicado: (2018)

Determinants of Disability in Multiple Sclerosis: An Immunological and MRI Study
por: Tortorella, Paola, et al.
Publicado: (2014)

NK Cell Subpopulations and Receptor Expression in Recovering SARS-CoV-2 Infection
por: Saresella, Marina, et al.
Publicado: (2021)

Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
por: D’Anca, Marianna, et al.
Publicado: (2021)

Influence of a High-Impact Multidimensional Rehabilitation Program on the Gut Microbiota of Patients with Multiple Sclerosis
por: Barone, Monica, et al.
Publicado: (2021)

Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2
por: Ambari, Ade M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v023b30k606lfu3015grsmgchu